Analgesic addiction and pseudoaddiction in painful chronic illness

Clinical Journal of Pain

Volumn 22, Issue 3, 2006, Pages 316-324

  Lusher, Joanne ^a   Elander, James ^b   Bevan, David ^c   Telfer, Paul ^d   Burton, Bernice ^e  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF WEST LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e Plaistow Hospital   (United Kingdom)

Author keywords

Analgesic addiction; Non pain related symptoms; Pain related symptoms; Pseudoaddiction; Sickle cell disease

Indexed keywords

ANALGESIC AGENT;

ADULT; ANALGESIC AGENT ABUSE; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG DEPENDENCE; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SICKLE CELL ANEMIA; ADDICTION; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; INCIDENCE; METHODOLOGY; PAIN; PROGNOSIS; RISK FACTOR; UNITED KINGDOM;

ADULT; ANALGESICS; ANEMIA, SICKLE CELL; CHRONIC DISEASE; COMORBIDITY; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; PAIN; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 33645746944     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ajp.0000176360.94644.41     Document Type: Article

References (42)

1. France RD, Urban BJ, Keefe FJ. Long-term use of narcotic analgesics in chronic pain. Soc Sci Med. 1984;19:1379-1382.
2. Portenoy RK, Foley KM. Chronic use of opioid analgesics in nonmalignant pain: report of 38 cases. Pain. 1986;25:171-186.
3. Drayer RA, Henderson J, Reidenberg M. Barriers to better pain control in hospitalised patients. J Pain Symptom Manage. 1999;17:434-440.
4. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:77-85.
5. Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002;18:S28-S38.
6. American Psychiatric Association. 2000. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision. Washington DC: American Psychiatric Association.
7. Sees KL, Clark HW. Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage. 1993;8:257-264.
8. Savage S, Covington EC, Heit HA, et al. (2001). Definitions Related to the Use of Opiates for the Treatment of Pain: A Consensus Document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. American Society of Addiction Medicine. http://www.asam.org/pain/definitions2.pdf
9. Savage SR, Joranson DE, Covington EC, et al. Definitions related to the medical use of opioids: evolution towards universal agreement. J Pain Symptom Manage. 2003;26:655-667.
10. Weissman DE, Haddox JD. Opioid pseudoaddiction: an iatrogenic syndrome. Pain. 1989;36:363-366.
11. Elander J, Lusher J, Bevan D, et al. Pain management and symptoms of substance dependence among patients with sickle cell disease. Soc Sci Med. 2003;57:1683-1696.
12. Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:203-217.
13. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage. 1998;16:355-363.
14. Robinson RC, Gatchel RJ, Polatin P, et al. Screening for problematic prescription opioid use. Clin J Pain. 2001;17:220-228.
15. Passik SD, Kirsh KL, McDonald MV, et al. A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J Pain Symptom Manage. 2000;19:274-286.
16. Anderson KO, Richman SP, Hurley J, et al. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer. 2002;94:2295-2304.
17. Green CR, Anderson KO, Baker TA, et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med. 2003;4:277-294.
18. Todd KH, Samaroo N, Hoffman JR. Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA. 1993;269:1537-1539.
19. Shapiro BS, Benjamin LJ, Payne R, et al. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14:168-174.
20. Waldrop RD, Mandry C. Health professionals' perceptions of opioid dependence among patients with pain. Am J Emerg Med. 1995;13:529-531.
21. Pack-Mabien A, Labbe E, Herbert D, et al. Nurses' attitudes and practices in sickle cell pain management. Appl Nurs Res. 2001;14:187-192.
22. Brozovic M, Davies SC, Yardumian A, et al. Pain relief in sickle cell crises [letter]. Lancet. 1986;2:624-625.
23. Morrison RA. Update on addiction and choice of opioid in pain management. Pediatr Nurs. 1991;17:503.
24. Payne R. Pain management in sickle cell disease: rationale and techniques. Ann NY Acad Sci. 1989;565:189-206.
25. Pegelow CH. Survey of pain management therapy provided for children with sickle cell disease. Clin Pediatr (Phila). 1992;31:211-214.
26. Vichinsky EP, Johnson R, Lubin BH. Multidisciplinary approach to pain management in SCD. Am J Pediatr Hematol Oncol. 1982;4:328-333.
27. Maxwell K, Streetly A, Bevan D. Experiences of hospital care and treatment for pain from sickle cell disease: qualitative study. Br Med J. 1999;318:1585-1590.
28. Harris A, Parker N, Barker C. Adults with sickle cell disease: psychological impact and experience of hospital services. Psychol Health Med. 1998;3:171-179.
29. Shelley B, Kramer KD, Nash KB. Sickle cell mutual assistance groups and the health care delivery system. In: Nash KB, ed. Psychosocial Aspects of Sickle Cell Disease: Past Present and Future Directions Of Research. New York: Haworth Press; 1994:243-259.
30. Elander J, Lusher J, Bevan D, et al. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage. 2004;27:156-169.
31. Kirsh KL, Whitcomb LA, Donaghy K, et al. Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain. 2002;18:S52-S60.
32. Elander J, Midence K. A review of evidence about factors affecting quality of pain management in sickle cell disease. Clin J Pain. 1996;12:180-193.
33. Jensen MP, Turner JA, Romano JM, et al. Coping with chronic pain: a critical review of the literature. Pain. 1991;47:249-283.
34. Gil KM, Abrams MR, Phillips G, et al. Sickle cell disease pain: relation of coping styles to adjustment. J Consult Clin Psychol. 1989;57:725-731.
35. Gil KM, Williams DA, Keefe FJ, et al. The relationship of negative thoughts to pain and psychological distress. Behav Ther. 1990;21:346-362.
36. Anie KA, Steptoe A, Bevan DH. Sickle cell disease: pain, coping and quality of life in a study of adults in the UK. Br J Health Psychol. 2002;7:331-344.
37. Midence K, Elander J. Adjustment and coping in adults with sickle cell disease: an assessment of research evidence. Br J Health Psychol. 1996;1:95-111.
38. Hung CI, Liu CY, Chen CY, et al. Meperidine addiction or treatment frustration? Gen Hosp Psychiatry. 2001;23:31-35.
39. Hair J, Anderson R, Tatham R, et al. Multivariate Data Analysis, 5th ed, New Jersey: Prentice Hall; 1998:164-166.
40. Geisser ME, Robinson ME, Henson CD. The coping strategies questionnaire and chronic pain adjustment: a conceptual and empirical reanalysis. Clin J Pain. 1994;10:98-106.
41. Jensen MP, Turner JA, Romano JM. Chronic pain coping measures: individual vs. composite scores. Pain. 1992;51:273-280.
42. Passik SD, Hay JL. Symptom control in patients with severe character pathology. In: Portenoy RK, Bruera E, eds. Topics in Palliative Care, Vol. 3, Chapter 9. New York and Oxford: Oxford University Press; 1998:213-227.